EcoDrugPlus

Adenosine Deaminase

Ensembl ID : ENSOSIG00000012449
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSOSIG00000017398
Gene Symbol: ADRA1AA
1 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSOSIG00000008217
Gene Symbol: ADRA1B
1 Cross references
186 Possible Orthologues:

Adrenoceptor Alpha 1bb

Ensembl ID : ENSOSIG00000022470
Gene Symbol: ADRA1BB
1 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSOSIG00000011473
Gene Symbol: ADRA1D
1 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSOSIG00000009026
Gene Symbol: ADRA2A
1 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSOSIG00000023268
Gene Symbol: ADRA2B
1 Cross references
174 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSOSIG00000022458
Gene Symbol: ADRA2B
1 Cross references
149 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSOSIG00000018748
Gene Symbol: ADRA2C
1 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSOSIG00000003108
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSOSIG00000017868
Gene Symbol: ADRB2
1 Cross references
192 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSOSIG00000022258
Gene Symbol: ADRB2A
1 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).